Pituitary & hypothalamus

Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study

Eur J EndocrinolPublished Proof-of-concept trial

Authors' conclusion

Our findings suggest that protein powder increases plasma sodium levels in patients with chronic SIAD through protein-induced ureagenesis and osmotic diuresis. The effects are comparable with oral urea.

Study context

Population
Outpatients with chronic Syndrome of Inappropriate Antidiuresis (SIAD), University Hospital of Basel, Switzerland, October 2021–February 2023
Participants
17 vs 10
Comparison
Protein supplementation followed by oral urea, each for 7 days
  • Proteinn = 17
  • Oral urean = 10
Outcome
Increase in sodium levels from baseline to end of 7-day protein supplementation
Follow-up
7 days
Methodological detailsopen-label, monocentric
  • Open-label
  • Monocentric

Main finding

As reported in the abstract

Plasma sodium with protein supplementation

Plasma sodium, baseline to day 7

131 (129-133) to 133 (132-137)

Median increase in plasma sodium, mmol L-1 (P = .01)

3

0–5

Further findings

Plasma urea and urine urea to creatinine ratio with protein · 7 days

Plasma urea increase, mmol L-1 (P < .01)
3 (1.7-4.9)
Urine urea to creatinine ratio increase, mmol mmol-1 (P < .01)
21.2 (6.2-29.1)

Oral urea: plasma sodium, plasma urea and urine urea to creatinine ratio · 7 days

Plasma sodium, baseline to day 7
132 (130-133) to 134 (131-136)
Median increase in plasma sodium, mmol L-1 (P = .06)
2 (1-3)
Plasma urea increase, mmol L-1 (P < .01)
5.8 (2.7-9.2)
Urine urea to creatinine ratio increase, mmol mmol-1 (P < .01)
31.0 (18.7-45.1)
  • n = 10

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effect of protein supplementation on plasma sodium levels in the syndrome of inappropriate antidiuresis: a monocentric, open-label, proof-of-concept study—the TREASURE study. Eur J Endocrinol. Published 4 August 2023. doi:10.1093/ejendo/lvad108

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.